We are not only facilitating compliance, we are helping to rebuild confidence in Puerto Rico as a destination for medical careers.
In Conversation
With the right expertise and collaborative spirit, there is no reason why Hong Kong should not be a leader in advanced cell therapies.
I do believe this is just the tip of the iceberg. Switzerland has built deep scientific excellence over decades, and we’re now seeing more entrepreneurial ambition,…
Switzerland is truly the place to be if you are a life sciences company willing to develop in Europe...we are all standing on the shoulders of…
While the larger companies in the API space may dominate the bulk market, there is a significant gap for companies like ours, who specialise in sourcing…
This transformation marks a new era for Unipharma, rooted in heritage but aligned with the realities of today’s pharmaceutical landscape.
We’re not just reconnecting with our roots—we’re planting new ones. The PDA Puerto Rico chapter is a bridge between our island’s rich pharmaceutical legacy and a…
Riccardo Braglia & Dr. Melanie Rolli – Executive Chairman and Group Chief Executive Officer, Helsinn
At the heart of this mindset is resilience, a deeply held commitment to perseverance, adaptability, and delivering long-term value without ever compromising the principles that define…
We’re not just building facilities—we’re building the future of medicine, where innovation is inclusive, access is equitable, and every breakthrough brings us closer to a healthier…
If we truly nurture this platform and understand its potential, it can transform not just healthcare, but the future of biomedical innovation in Hong Kong.
Saudi Arabia is not just transforming its healthcare system under Vision 2030—we are reimagining what is possible for human health globally.
Healthcare systems and governments must move faster, plan better, and work more collaboratively with the other health stakeholders. Only by doing that will we be able…
